Congratulations to Dr. Marko Bergovec and his research team at Medical University Graz for enrolling their first PARITY participant on February 11th 2018!
Thank you to all those who continue to screen patients that present to clinic with a bone tumor of the femur or tibia for inclusion in the trial. Let’s keep the momentum going to make 2019 our final year of recruitment!
Please join us in extending a warm congratulations to Dr. Joseph Schwab, Christine Park and Gi Hye Im at Massachusetts General Hospital (Boston, MA) for enrolling their first PARITY participant on 17 September 2015! There are currently 32 sites actively screening and enrolling patients into the PARITY trial across Canada, the United States, Australia and Argentina.
Thank you to all those who continue to screen patients for inclusion into the trial. Without you the success of the trial would not be possible.
On Thursday, October 16th from 12 – 1PM Central European Time Zone, we will be hosting an Investigators Meeting to discuss the PARITY trial. We will hold this meeting in the InterContinental Berlin Hotel Knight Conference Room in Berlin, Germany. All co-investigators and study coordinators are invited to attend. The purpose of this meeting is to discuss the transition from the pilot to the definitive study and international expansion.
In order to facilitate your attendance, we have scheduled this meeting to coincide with the Connective Tissue Oncology Society (CTOS) annual meeting. A buffet lunch will be served.
Please share this memo with other study personnel at your site and encourage all individuals involved in the PARITY trial to attend.
Please RSVP to Paula McKay (firstname.lastname@example.org) or Tricia Schneider (email@example.com) by October 10, 2014. If you have any questions concerning this meeting, please feel free to contact the PARITY Methods Centre (905-527-4322 ext. 44983).
We look forward to seeing you in Berlin!